⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Admerus Biosciences Private Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Admerus Biosciences Private Limited
↗Hyderabad, India
Admerus Biosciences is a Hyderabad-based Contract Research Organization (CRO) established in 2015. The company provides specialized services to the global biopharmaceutical industry, focusing on preclinical services, drug testing, and clinical trial operations, including bioequivalence and bioavailability studies.
The company operates modern facilities in Hyderabad and is recognized for its commitment to global regulatory standards, including certifications from bodies such as ANVISA. Admerus positions itself as a partner for biopharma companies seeking cost-effective and efficient solutions for their clinical development programs.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$25M
Founded:2015
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:Global biopharmaceutical companies, Academic research laboratories
COMPETITION
Position:Niche Player
Competitors:Syngene International, Jubilant Biosys, Aragen Life Sciences, Accutest Research Laboratories
LEADERSHIP
Key Executives:
Abhiram Koppineedi - Managing Director
Dr. Sanjeeva Reddy K. - Vice President - Clinical Research
Dr. Susanta Kumar Pradhan - Associate Vice President - Quality & Compliance
Scientific Founders:Abhiram Koppineedi
Board Members:Pattabhi Ram Koppineedi, China Gangaiah Koppineedi, Jayasree Koppineedi, Venkata Nageswararao Koppineedi
LINKS
Website:admerus.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Admerus Biosciences Private Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.